NCT06205355

Brief Summary

This study aims to determine whether goal-directed analgesia using ANI(Analgesia/Nociception Index) can improve the quality of postoperative recovery in patients undergoing maxillofacial surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
8mo left

Started Jan 2024

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Jan 2024Dec 2026

First Submitted

Initial submission to the registry

December 13, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 16, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

January 25, 2024

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2026

Expected
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

January 16, 2024

Status Verified

January 1, 2024

Enrollment Period

2.9 years

First QC Date

December 13, 2023

Last Update Submit

January 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative QoR-15K score

    Korean-translated QoR-15K (15-item Quality of Recovery (QoR-15) scale, minimum 0, maximum 150, higher scores mean a better outcome ) scores assessed by participants blinded to arm assignment 24 hours after surgery.

    24 hours after the end of surgery

Secondary Outcomes (14)

  • Patient satisfaction

    24 hours after the end of surgery

  • intraoperative opioid consumption

    during surgery

  • intraoperative non-opioid consumption

    during surgery

  • intraoperative use of vasoactive drugs

    during surgery

  • The time-weighted average of the segments of the total anesthesia time where the ANI value did not remain above 50 and below 70.

    during surgery

  • +9 more secondary outcomes

Study Arms (2)

goal-directed analgesia using ANI monitoring

EXPERIMENTAL
Device: Analgesia/Nociception Index (ANI) monitoring

Standard monitoring

ACTIVE COMPARATOR
Device: Standard monitoring

Interventions

intraoperative analgesia was provided by infusion of remifentanil via target controlled infusion mode, which was controlled according to ANI monitor.

goal-directed analgesia using ANI monitoring

intraoperative analgesia was provided by infusion of remifentanil via target controlled infusion mode, which was controlled according to the clinician's decision

Standard monitoring

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients 18 or older undergoing maxillary, mandibular, or bimaxillary surgery under general anesthesia.
  • adult patients who can provide written informed consent to participate in the study, understand the procedures of this study, and be able to complete patient-reported questionnaires adequately.
  • adult patients who Have made an informed decision to participate in this study and have given written consent.

You may not qualify if:

  • Patients with ASA physical status 4-5
  • Emergency surgery
  • Patients with chronic pain and related pain medications
  • Patients with hypersensitivity to general anesthesia drugs and pain medications
  • Patients with arrhythmia
  • Pregnant women
  • Others deemed unsuitable by the investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Children's Hospital

Seoul, 03080, South Korea

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Analgesia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

December 13, 2023

First Posted

January 16, 2024

Study Start

January 25, 2024

Primary Completion (Estimated)

December 25, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

January 16, 2024

Record last verified: 2024-01

Locations